ICU Medical (ICUI) last issued guidance on February 19, 2026 for fiscal year 2026. The company guided earnings per share in the range of $7.75 - $8.45, compared to a consensus EPS estimate of $7.41.
Compared to prior guidance, ICU Medical raised its EPS outlook from a previous range of $7.35 - $7.65.
ICU Medical has issued 13 guidance updates between August 8, 2022 and February 19, 2026. During this period, the company raised its outlook 6 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
Review all historical guidance issued by ICU Medical, including EPS and revenue forecasts across quarterly and annual periods.
The most recent guidance for ICU Medical (ICUI) was reported on February 19, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $7.75 to $8.45, compared to the estimated EPS of $7.41.
ICU Medical (ICUI) guided EPS in the range of $7.75 to $8.45 for the fiscal year 2026. The consensus analyst EPS estimate is $7.41.
ICU Medical (ICUI) raised its EPS guidance from a prior range of $7.35 - $7.65 to $7.75 - $8.45 for the fiscal year 2026.
ICU Medical (ICUI) last issued guidance on February 19, 2026 for the fiscal year 2026.